Autoradiography with [3H]8-OH-DPAT reveals increases in 5-HT1A receptors in ventral prefrontal cortex in schizophrenia

Biological Psychiatry

Volumn 39, Issue 11, 1996, Pages 919-928

  Simpson, Michael D C ^a   Lubman, Daniel I ^a   Slater, Paul ^a   Deakin, J F William ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

5 HT1A receptor; Autoradiography; Frontal cortex; Postmortem brain; Schizophrenia; Serotonin

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; GLUTAMIC ACID; SEROTONIN RECEPTOR; DIAGNOSTIC AGENT; SEROTONIN AGONIST;

ADULT; ARTICLE; AUTORADIOGRAPHY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; MALE; PREFRONTAL CORTEX; PRIORITY JOURNAL; SCHIZOPHRENIA; METABOLISM; MIDDLE AGED;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; AUTORADIOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; PREFRONTAL CORTEX; RECEPTORS, SEROTONIN; SCHIZOPHRENIA; SEROTONIN AGONISTS;

EID: 0029658084     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-3223(95)00026-7     Document Type: Article

References (46)

1. Aranz B, Eriksson A, Mellerup E, Plenge P, Marcusson J (1994): Brain 5HT1A, 5HT1D and 5HT2 receptors in suicide victims. Biol Psychiatry 35:457-463.
2. Arora RC, Meltzer HY (1991): Serotonin 2 (5-HT2) receptor binding in the frontal cortex of schizophrenic patients. J Neural Transm Gen Sect 85:19-29.
3. Balderson DJ, Roberts DA, Owen F, Deakin JFW (1994): Increased abundance of 5HT1A receptor mRNA in schizophrenic orbital frontal cortex. Schizophr Res 11:124.
4. Benes FM, Bird ED (1987): An analysis of the arrangement of neurones in the cingulate cortex of schizophrenic patients. Arch Gen Psychiatry 44:608-616.
5. Benes FM, Davidson J, Bird ED (1986): Quantitative cytoarchitectural analyses of the cerebral cortex of schizophrenics. Arch Gen Psychiatry 43:31-35.
6. Benes FM, Majocha R, Bird ED, Marotta CA (1987): Increased vertical axon numbers in the cingulate cortex of schizophrenics. Arch Gen Psychiatry 44:1017-1021.
7. Benes FM, McSparren J, Bird ED, SanGiovanni JP, Vincent SL (1991): Deficits in small interneurones in prefrontal and cingulate cortices of schizophrenic and schizoaffective patients. Arch Gen Psychiatry 48:996-1001.
8. Benes FM, Sorensen I, Vincent SL, Bird ED, Sathi M (1992): Increased density of glutamate-immunoreactive vertical processes in superficial laminae in cingulate cortex of schizophrenic brain. Cereb Cortex 2:503-512.
9. Bennett JP, Enna SJ, Bylund DB, Gillin JC, Wyatt RJ, Snyder SH (1979): Neurotransmitter receptors in frontal cortex of schizophrenics. Arch Gen Psychiatry 36:927-934.
10. Biegon A, Kargman S, Snyder L, McEwen BS (1986): Characterization and localization of serotonin receptors in human brain postmortem. Brain Res 363:91-98.
11. Cheetham SC, Crompton MR, Katona CLE, Horton RW (1990): Brain 5HT1 binding sites in depressed suicides. Psychopharmacology (Berl) 102:544-548.
12. Cross AJ, Deakin JFW (1985): Cortical serotonin receptor subtypes after lesioning of ascending cholinergic neurones in rats. Neurosci Lett 60:261-265.
13. Crow TJ (1990): Temporal lobe asymmetries as the key to the etiology of schizophrenia. Schizophr Bull 16:433-443.
14. Dawson JM, Heatlie PL (1984): Lowry method of protein quantification: Evidence for photosensitivity. Anal Biochem 51:429-435.
15. Deakin JFW, Slater P, Simpson MDC, Gilchrist AC, Skan WJ, Royston MC, Reynolds GP, Cross AJ (1989): Frontal cortical and left temporal glutamatergic dysfunction in schizophrenia. J Neurochem 52:1781-1786.
16. DeFelipe J, Jones EG (1988): Cajal on the Cerebral Cortex. Oxford: Oxford University Press, pp. 557-621.
17. Dillon KA, Gross-Isseroff R, Israeli M, Biegon A (1991): Autoradiographic analysis of serotonin 5-HT1A receptor binding in the human brain postmortem: Effects of age and alcohol. Brain Res 554:56-64.
18. Feighner JP, Robins E, Guzes SP, Woodruff RA, Winokur E, Munoz RJ (1972): Diagnostic criteria for use in psychiatric research. Arch Gen Psychiatry 26:57-63.
19. Francis PT, Pangalos MN, Pearson RCA, Middlemiss DN, Stratmann GC, Bowen DM (1992): 5-Hydroxytryptamine-1A but not 5-hydroxytryptamine-2 receptors are enriched on neocortical pyramidal neurones destroyed by intrastriatal volkensin. J Pharmacol Exp Ther 261:1273-1281.
20. Francis PT, Pangalos MN, Stephens PH, Bartlett JR, Bridges PK, Malizia AL, Neary D, Procter AW, Thomas DJ, Bowen DM (1993): Antemortem measurements of neurotransmission: Possible implications for pharmacotherapy of Alzheimer's disease and depression. J Neurol Neurosurg Psychiatry 56: 80-84.
21. Fuster J (1980): The Prefrontal Cortex. New York: Raven Press.
22. Galaburda AM, Pandya DN (1983): The intrinsic architectonic and connectional organisation of the superior temporal region of the rhesus monkey. J Comp Neurol 221:169-184.
23. Goff DC, Midha KK, Brotman AW, McCormick S, Waites M, Amico ET (1991): An open trial of buspirone added to neuroleptics in schizophrenic patients. J Clin Psychopharmacol 11:193-197.
24. Hall MD, Mestikawy EC, Emerit S, Pichat MB, Hamon M, Gozlan H (1985): 3H-8-hydroxy-2(di-n-propylamino)tetralin binding to pre and postsynaptic 5-hydroxytryptamine sites in various regions of the rat brain. J Neurochem 44:1685-1696.
25. Hashimoto T, Nishino N, Nakai H, Tanaka C (1991): Increase in serotonin 5-HT1A receptors in prefrontal and temporal cortices of brains from patients with chronic schizophrenia. Life Sci 48:355-363.
26. Hoyer D, Pazos A, Probst A, Palacios JM (1986): Serotonin receptors in the human brain. I. Characterisation and autoradiographic localization of 5-HT1A recognition sites. Apparent absence of 5-HT1B recognition sites. Brain Res 376:85-96.
27. Joyce JN, Shane A, Lexow N, Winokur A, Casanova MF, Kleinman JE (1993): Serotonin uptake sites and serotonin receptors are altered in the limbic system of schizophrenics. Neuropsychopharmacology 8:315-336.
28. Kerwin RW, Patel S, Meldrum BS, Czudek C, Reynolds GP (1988): Asymmetrical loss of glutamate receptor subtype in left hippocampus in schizophrenia. Lancet 1:583-584.
29. Mason SL, Reynolds GP (1992): Clozapine has sub-micromolar affinity for 5-HT1A receptors in human brain tissue. Eur J Pharmacol 221:397-398.
30. Matsubara S, Arora RC, Meltzer HY (1991): Serotonergic measures in suicide brain: 5HT1A binding sites in frontal cortex of suicide victims. J Neural Transm 85:181-194.
31. Maura G, Barzizza A, Folghera S, Raiteri M (1991a): Release of endogenous aspartate from rat cerebellum slices and synaptosomes: Inhibition mediated by a 5-HT2 receptor and by a 5-HT1 receptor of a possibly novel subtype. Naunyn Schmiedebergs Arch Pharmacol 343:229-236.
32. Maura G, Carbone R, Guido M, Pestarino M, Raiteri M (1991b): 5-HT2 presynaptic receptors mediate inhibition of glutamate release from cerebellar mossy fibre terminals. Eur J Pharmacol 202:185-190.
33. Meltzer HY (1991): The mechanism of action of novel antipsychotic drugs. Schizophr Bull 17:263-287.
34. Meltzer HY, Bastani B, Ramirez L, Matsubara S (1989): Clozapine: New research on efficacy and mechanism of action. Eur Arch Psychiatry Neurol Sci 238:332-339.
35. Miller JA, Hoffer BJ, Zahniser NR (1987): An improved calibration procedure for computer based autoradiography utilizing a mathematical model for the non-linear response of camera and film. J Neurosci Methods 22:233-238.
36. Mita T, Hanada S, Nishino N, Kuno T, Nakai H, Yamadori T, Mizoi Y, Tanaka C (1986): Decreased serotonin S2 and increased dopamine D2 receptors in chronic schizophrenics. Biol Psychiatry 21:1407-1414.
37. Montemurro DG, Bruni JE (1988): The Human Brain in Dissection. Oxford: Oxford University Press.
38. 3H-kainic acid binding in the pre-frontal cortex in schizophrenia. Neurosci Lett 40:245-250.
39. Pazos A, Probst A, Palacios JM (1987): Serotonin receptors in the human brain - III. Autoradiographic mapping of serotonin-1 receptors. Neuroscience 21:97-122.
40. Pompeiano M, Palacios JM, Mengod G (1992): Distribution and cellular localization of messenger RNA coding for 5-HT1A receptor in the rat brain - correlation with receptor binding. J Neurosci 12:440-453.
41. Reynolds GP (1991): Amino acid transmitters and dopamine function in the brain in schizophrenia. In Racagni G, Brunello N, Fokuda T (eds), Biological Psychiatry. Amsterdam: Excerpta Medica, pp. 491-494.
42. Simpson MDC, Slater P, Deakin JFW, Royston MC, Skan WJ (1989): Reduced GABA uptake sites in the temporal lobe in schizophrenia. Neurosci Lett 107:211-215.
43. Simpson MD, Slater P, Royston MC, Deakin JF (1991): Alterations in phencyclidine and sigma binding sites in schizophrenic brains. Effects of disease process and neuroleptic medication. Schizophr Res 6:41-48.
44. Slater P, McConnell S, D'Souza SW, Barson AJ, Simpson MDC, Gilchrist AC (1992): Age-related changes in binding to excitatory amino acid uptake sites in temporal cortex of human brain. Dev Brain Res 2:157-160.
45. Sovner R, Parnell-Sovner N (1989): Use of buspirone in the treatment of schizophrenia. J Clin Psychopharmacol 9:61-62.
46. Whitaker PM, Crow TJ, Ferner IN (1981): Tritiated LSD binding in frontal cortex in schizophrenia. Arch Gen Psychiatry 38:278-280.